<DOC>
	<DOC>NCT02744365</DOC>
	<brief_summary>The Biobank includes data and biological specimens of women from three original studies: 1) First-trimester Prediction of Preeclampsia (PREDICTION Study, NCT02189148), 2) Pre-Eclampsia And growth Retardation, an evaluative Longitudinal study (PEARL Study, NCT02379832), 3) Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial (NCT02280031) and 4)PREDICTION2: Prediction of Preeclampsia and other Pregnancy Complications Following Combined Iterative Screening.</brief_summary>
	<brief_title>Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications</brief_title>
	<detailed_description>This Biobank is comprised of: 1) medical, social, obstetrical and ultrasonographic data, 2) human biological samples (maternal plasma, serum and buffy coat, maternal urine, cord blood) and 3) the results derived from these (biochemical or ultrasonographic markers, genetics, risk calculations ...)</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<criteria>(specific to each study) pregnant women &lt;18 years old at recruitment negative fetal heart at recruitment women not able to provide an informed consent to the study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>